Y-mAbs Therapeutics

Works in Dermatology · Hematology · Immunology · Neurology · Oncology

Y-mAbs Therapeutics is a clinical trial sponsor. It has 1 active clinical trial with 122 planned participants, across 5 therapeutic areas. Since 2021 it has completed 1 trial and stopped 13 early.

Trial track record · since 2021

1Active trials122 planned participants
1Completed6 with results posted
13Stopped early93% of finished trials

Pipeline · 1 active trial

StageTrialStatus

On the market

1 approved drug application with a product on the market.

Questions about Y-mAbs Therapeutics

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-07-30.

Approve Suite is not affiliated with Y-mAbs Therapeutics.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.